A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy
A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy
Recruiting · NCT07289477 · Registry updated 2026-04-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy | Multiple System Atrophy - Parkinsonian Subtype (MSA-P) | Recruiting | Phase 1 | 2026-04-14 | NCT07289477 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| iRegene Therapeutics Co., Ltd. | 8 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tiantan Hospital, Capital Medical University | Beijing | China | 1 |